Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M335Revenue $M0.8Net Margin (%)-7,138.4Z-Score1.0
Enterprise Value $M275EPS $-0.7Operating Margin %-7,214.1F-Score4
P/E(ttm))0Cash Flow Per Share $-0.7Pre-tax Margin (%)-7,138.4Higher ROA y-yN
Price/Book9.110-y EBITDA Growth Rate %-12.1Quick Ratio5.0Cash flow > EarningsY
Price/Sales4005-y EBITDA Growth Rate %15.1Current Ratio5.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-79.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-115.6Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M101ROI % (ttm)-167.5Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJean-Marie Eveillard 2013-06-30 Sold Out $1.52 - $2.621
($1.85)
$ 3.3380%Sold Out0
ZIOPJean-Marie Eveillard 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 3.33-25%New holding, 200000 sh.200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.5-4.86 view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.2-35.96 view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.99-33.27 view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.92-32.32 view
Fowler WycheDirector 2011-08-10Buy5,000$5.19-35.84 view
KIRK RANDAL JDirector, 10% Owner 2011-08-09Buy846,522$4.78-30.33 view
WEISER MICHAELDirector 2011-05-25Sell15,000$6.53-49 view
BRENNAN MURRAYDirector 2011-05-09Sell15,000$6.57-49.32 view
KIRK RANDAL JDirector, 10% Owner 2011-02-03Buy1,910,000$5.75-42.09 view
MCINERNEY TIMOTHYDirector 2009-12-09Buy50,000$3.17.42 view

Press Releases about ZIOP :

    Quarterly/Annual Reports about ZIOP:

    News about ZIOP:

    Articles On GuruFocus.com
    Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
    Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
    The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 
    comment on ZIOP Mar 15 2013 
    cooldecency99 note on ZIOP May 01 2010 
    ZIOPHARM Reports Second Quarter Financial Results and Updates Clinical Programs Aug 14 2009 

    More From Other Websites
    ZIOPHARM ONCOLOGY INC Financials Aug 15 2014
    ZIOPHARM Reports Second-Quarter 2014 Financial Results and Reviews Recent Activities Aug 07 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 07 2014
    ZIOPHARM Reports Second-Quarter 2014 Financial Results and Reviews Recent Activities Aug 07 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 10-Q, Quarterly Report Aug 07 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 31 2014
    ZIOPHARM Oncology and Solasia Pharma Announce Global License and Collaboration Agreement for... Jul 31 2014
    ZIOPHARM Announces Expansion of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon and... Jul 22 2014
    ZIOPHARM Announces Expansion of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon and... Jul 22 2014
    ZIOPHARM Announces Expansion of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon and... Jul 22 2014
    Why Ziopharm Looks Worth Adding To Your Biotechnology Portfolio Pipeline Jul 14 2014
    Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology,... Jun 27 2014
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 19 2014
    ZIOPHARM Oncology to Present at the 9th Annual JMP Securities Healthcare Conference Jun 18 2014
    The Sirens Of Ziopharm Jun 15 2014
    Mid-Morning Market Update: Markets Gain On Jobs Data; VeriFone Earnings Beat Estimates Jun 06 2014
    Can the Uptrend Continue for ZIOPHARM (ZIOP)? Jun 06 2014
    Ziopharm - A Stock Worth Owning To Benefit Your Portfolio This Year And Beyond May 28 2014
    Comparison Shopping For Small-Cap Biotech Deals May 23 2014
    ZIOPHARM Presents Encouraging Data May 23 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide